Table 3 Baseline characteristics, comorbidities and outcomes in patients from high risk country of origin for TB (> 100 cases per 100,000 population per year) comparing those not screened with screened for LTBI using QFG
From: Tuberculosis screening practices and outcomes in an australian dialysis unit
Not screened | Screened | Significance | ||
|---|---|---|---|---|
Total | 37 | 70 | ||
Gender | Male | 17 (45.9%) | 45 (64.3%) | 0.07 |
Female | 20 (53.1%) | 25 (35.7%) | ||
Smoker | Never | 26 (70.3%) | 37 (52.5%) | 0.31 |
Former | 8 (21.6%) | 25 (35.7%) | ||
Current | 2 (5.4%) | 8 911.4%) | ||
Age | 71 ± 8 | 52 ± 11 | < 0.01 | |
Lung disease | 3 (8.1%) | 5 (7.1%) | 0.86 | |
Coronary disease | 10 (27%) | 15 (21.4%) | 0.5 | |
PVD | 4 (10.8%) | 10 (14.3) | 0.61 | |
CVD | 4 (10.8%) | 4 (5.7%) | 0.34 | |
Diabetes | 25 (67.6%) | 38 (54.3%) | 0.18 | |
IS | 1 (2.7%) | 5 (7.2%) | 0.33 | |
Cancer Diagnosis | 3 (8.1%) | 2 (2.9%) | 0.22 | |
Active TB | During study | 0 | 1 (1.4%) | 0.56 |
Pre study | 3 (8.1%) | 3 (4.2%) | ||
Death | 10 (27%) | 6 (8.7%) | 0.01 |